These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30746767)

  • 1. Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key? Authors' reply.
    Poynard T; Deckmyn O; Housset C;
    Aliment Pharmacol Ther; 2019 Mar; 49(5):613-614. PubMed ID: 30746767
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key?
    Drake TM; Bird TG
    Aliment Pharmacol Ther; 2019 Mar; 49(5):612-613. PubMed ID: 30746772
    [No Abstract]   [Full Text] [Related]  

  • 3. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
    Poynard T; Peta V; Deckmyn O; Munteanu M; Moussalli J; Ngo Y; Rudler M; Lebray P; Pais R; Bonyhay L; Charlotte F; Thibault V; Fartoux L; Lucidarme O; Eyraud D; Scatton O; Savier E; Valantin MA; Ngo A; Drane F; Rosmorduc O; Imbert-Bismut F; Housset C; Thabut D; Ratziu V;
    Aliment Pharmacol Ther; 2019 Feb; 49(3):308-320. PubMed ID: 30569507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C - authors' reply.
    Calès P; Boursier J
    Aliment Pharmacol Ther; 2017 May; 45(9):1276-1277. PubMed ID: 28370034
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: To PMID 24677195.
    Mourad A; Mathurin P; Deuffic-Burban S
    Gastroenterology; 2014 Oct; 147(4):936-7. PubMed ID: 25150789
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: in vino veritas--transient elastography for staging liver fibrosis in alcoholic liver disease--authors' reply.
    Pavlov C; Casazza G; Nikolova D; Gluud C
    Aliment Pharmacol Ther; 2016 May; 43(9):1015-6. PubMed ID: 27040165
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: rifaximin in cirrhosis-is this what we've been waiting for? Authors' reply.
    Kang SH; Lee YB; Lee JH
    Aliment Pharmacol Ther; 2017 Nov; 46(10):1017-1018. PubMed ID: 29052857
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: sepsis in cirrhosis - there may be trouble ahead; authors' reply.
    Salameh H; Kamath PS; Singal AK
    Aliment Pharmacol Ther; 2014 Sep; 40(5):567-8. PubMed ID: 25103352
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis-Authors' reply.
    Mandorfer M; Reiberger T; Ferlitsch A;
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1537-1538. PubMed ID: 29878416
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: evaluating cirrhosis progression-lessons from the heart. Authors' reply.
    Mookerjee RP; Thomsen KL
    Aliment Pharmacol Ther; 2019 Sep; 50(6):710-711. PubMed ID: 31456296
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Authors' reply.
    Artru F; Louvet A; Hazzan M; Mathurin P
    Aliment Pharmacol Ther; 2019 Aug; 50(4):457-458. PubMed ID: 31359475
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: moving towards a robust definition of sarcopenia in cirrhosis-authors' reply.
    Engelmann C; Schob S; Seehofer D; Berg T
    Aliment Pharmacol Ther; 2019 Feb; 49(3):341-342. PubMed ID: 30663101
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis-Authors' reply.
    Mettke F; Wedemeyer H
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1231-1232. PubMed ID: 29574871
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: the role of statins in the treatment of alcohol-related cirrhosis - Authors' reply.
    Bang UC; Benfield T; Bendtsen F
    Aliment Pharmacol Ther; 2017 Nov; 46(9):893-894. PubMed ID: 29023883
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits? Authors' reply.
    Støy S; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1555-1556. PubMed ID: 29878413
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: transplantation in the setting of acute-on-chronic liver failure-calculating chances. Authors' reply.
    Huebener P; Sterneck M; Fuhrmann V
    Aliment Pharmacol Ther; 2018 Jul; 48(1):100-101. PubMed ID: 29882978
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: the impact of steatosis on liver stiffness quantification is minimal-Authors' reply.
    Karlas T; Petroff D; Wiegand J
    Aliment Pharmacol Ther; 2018 May; 47(10):1417-1418. PubMed ID: 29676009
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: neutrophil dysfunction in patients with cirrhosis--authors' reply.
    Taylor NJ; Ma Y; Shawcross DL
    Aliment Pharmacol Ther; 2014 Oct; 40(8):987. PubMed ID: 25229816
    [No Abstract]   [Full Text] [Related]  

  • 19. RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Majeed A; Roberts SK; Kemp W
    Gastroenterology; 2019 Mar; 156(4):1217. PubMed ID: 30543798
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis - Authors' reply.
    Granito A; Bolondi L
    Lancet Oncol; 2017 Apr; 18(4):e193. PubMed ID: 28368255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.